Market Closed -
Nasdaq
20:56:35 14/06/2024 BST
5-day change
1st Jan Change
2.11
USD
-3.87%
-1.87%
-39.02%
Presentation Operator MessageOperator (Operator)Good day, and welcome to our Nephros, Inc.'s T...
This article is reserved for subscribers
Signed up already?
Log In Not subscribed yet?
Subscribe
Nephros, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
05-09
CI
Transcript : Nephros, Inc., Q1 2024 Earnings Call, May 09, 2024
05-09
Transcript : Nephros, Inc., Q4 2023 Earnings Call, Mar 07, 2024
03-07
Nephros, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
03-07
CI
Transcript : Nephros, Inc., Q3 2023 Earnings Call, Nov 08, 2023
11-08
Earnings Flash (NEPH) NEPHROS Posts Q3 Revenue $3.7M, vs. Street Est of $3.37M
11-08
MT
Nephros, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-08
CI
Nephros, Inc., Hires Judy Krandel as Chief Financial Officer
11-01
CI
Earnings Flash (NEPH) NEPHROS Posts Q2 Revenue $3.5M, vs. Street Est of $3.1M
09/08/23
MT
Transcript : Nephros, Inc., Q2 2023 Earnings Call, Aug 09, 2023
09/08/23
Nephros, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
09/08/23
CI
Transcript : Nephros, Inc., Q1 2023 Earnings Call, May 10, 2023
10/05/23
Nephros, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
10/05/23
CI
Nephros, Inc. Announces Management Changes
08/05/23
CI
Nephros, Inc. Announces CEO Changes
08/05/23
CI
Nephros, Inc. Announces Preliminary Revenue Results for the First Quarter Ended March 31, 2023
04/04/23
CI
Transcript : Nephros, Inc., Q4 2022 Earnings Call, Mar 08, 2023
08/03/23
Nephros, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
08/03/23
CI
Nephros, Inc. and Donastar Enterprises Llc Announce Strategic Partnership
01/03/23
CI
Nephros, Inc. Announces Board Changes
03/02/23
CI
Nephros, Inc. Provides Revenue Guidance for the Fourth Quarter and Fiscal Year Ended December 31, 2022
11/01/23
CI
Blue Water Solutions, Inc. completed the acquisition of Substantially all of Pathogen Detection Systems Business of Nephros, Inc..
14/11/22
CI
Transcript : Nephros, Inc., Q3 2022 Earnings Call, Nov 02, 2022
02/11/22
Nephros, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2022
02/11/22
CI
B. Riley Securities Lowers Nephros' Price Target to $4.25 from $5.25 Ahead of Q3 Results, Lowers Estimates; Maintains Buy Rating
19/10/22
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. It operates through the Water Filtration segment. In the medical markets, it sells water filtration products. In the commercial markets, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. Its products are marketed primarily to the food service, hospitality, convenience store, and health care markets. These commercial products are also marketed into medical markets, as supplemental filtration to its medical filters. The Companyâs filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
More about the company
Last Close Price
2.11
USD
Average target price
4.75
USD
Spread / Average Target
+125.12%
Consensus
1st Jan change
Capi.
-39.02% 22.25M +9.72% 8.63B +45.03% 2.47B -14.28% 1.01B +15.29% 817M +27.30% 761M -20.24% 561M -5.68% 545M +6.93% 531M -5.60% 489M
Purification & Treatment Equipment
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1